Our research facility generates internationally recognized work in the fields of dementia and childhood behavioral/developmental disorders. Our 2009 study on Neurofeedback and Dementia was presented at the International Conference on Alzheimer's Disease (ICAD) in Vienna this past summer. Out of thousands of researchers, we were the only presenter offering a non-drug treatment option for those with Alzheimer's disease.

The Foundation's unique approach integrates neurofeedback and other breakthrough techniques. Our results offer the most promising avenue for expanding the academic prospects of children with learning handicaps and adults suffering from brain dysfunction.

What is a clinical trial?

A clinical trial is research using human volunteers to answer a specific health question. For example: "Does this new treatment provide me with improved mood and cognitive functioning?"

Why participate in a trial?

For eligible participants, a clinical trial can provide access to new treatments before they are commercially available.

Am I a candidate?

Each clinical trial listed here includes specific inclusion criteria (factors that allow someone to participate) and exclusion criteria (factors that disallow someone from participating). Interested individuals should carefully review these basic requirements before contacting the study coordinator about participation.

We are currently conducting two clinical trials, both addressing the symptoms of early-stage dementia.

Call Dr. Marvin Berman (610-940-0488) to discuss participation.